Anúncio
Anúncio

CLGN

CLGN logo

CollPlant Biotechnologies Ltd Ordinary Shares

1.47
USD
Patrocinado
+0.03
+2.15%
09 de jan., 13:19 UTC -5
Abrir

Relatórios de Lucros CLGN

Rácio de surpresa positiva

CLGN separação 3 de 25 últimas estimativas.

12%

Próximo Relatório

Data do Próximo Relatório
24 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.55M
/
-$0.12
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1919.47%
/
-55.56%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+848.16%
/
-64.71%

CollPlant Biotechnologies Ltd Ordinary Shares earnings per share and revenue

On 26 de nov. de 2025, CLGN reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of 0.15 USD, resulting in a -270.78% surprise. Revenue reached 77.00 mil, compared to an expected 4.94 milhão, with a -98.44% difference. The market reacted with a -0.45% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.12 USD, with revenue projected to reach 1.55 milhão USD, implying an diminuir of -55.56% EPS, and aumentar of 1919.47% in Revenue from the last quarter.
FAQ
For Q3 2025, CollPlant Biotechnologies Ltd Ordinary Shares reported EPS of -$0.27, missing estimates by -270.78%, and revenue of $77.00K, -98.44% below expectations.
The stock price moved down -0.45%, changed from $2.24 before the earnings release to $2.23 the day after.
The next earning report is scheduled for 24 de mar. de 2026.
Based on 4 analistas, CollPlant Biotechnologies Ltd Ordinary Shares is expected to report EPS of -$0.12 and revenue of $1.55M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio